# PNLIPRP3

## Overview
PNLIPRP3, or pancreatic lipase related protein 3, is a gene that encodes a protein belonging to the pancreatic lipase family, which is primarily involved in lipid metabolism. The protein encoded by PNLIPRP3 plays a significant role in the digestive process by catalyzing the hydrolysis of dietary triglycerides into free fatty acids and monoglycerides, thus facilitating their absorption in the small intestine. This enzymatic activity is crucial for maintaining energy homeostasis within the body. While PNLIPRP3 is predominantly expressed in the pancreas, its presence has also been noted in other biological contexts, such as saliva, where it may participate in broader metabolic processes (Łopucki2018Preliminary). Additionally, its expression has been observed to change in response to certain hormonal treatments, suggesting a potential role in cellular signaling pathways (Tripathi2022Quantitative). Despite these findings, the complete spectrum of PNLIPRP3's functions and its implications in health and disease are still under investigation.

## Structure


## Function
PNLIPRP3 (pancreatic lipase related protein 3) is involved in lipid metabolism, primarily expressed in the pancreas, and is part of the pancreatic lipase family. This protein plays a crucial role in the digestion of dietary fats by breaking down triglycerides into free fatty acids and monoglycerides, facilitating their absorption in the digestive tract. The protein's activity is essential for efficient lipid digestion and absorption, contributing to overall energy homeostasis in the body.

In the context of physiological processes, PNLIPRP3 has been identified in studies analyzing protein profiles in saliva during term and preterm deliveries. Although its intensity did not differ significantly between control and preterm groups, it is suggested to have roles in cell metabolism, although not considered clinically significant in pregnancy contexts (Łopucki2018Preliminary). Additionally, PNLIPRP3 was found to be upregulated in a study examining the effects of GnRH agonist treatment on a glioblastoma cell line, indicating its potential involvement in cellular responses to hormonal treatments (Tripathi2022Quantitative). Despite these findings, the specific molecular functions of PNLIPRP3 in healthy human cells remain to be fully elucidated.

## Clinical Significance
PNLIPRP3 (pancreatic lipase related protein 3) is implicated in various digestive conditions due to its role in lipid metabolism. Alterations in the expression of PNLIPRP3 can lead to malabsorption syndromes, where the body's ability to absorb fats and other nutrients is compromised. This can result in symptoms such as diarrhea, weight loss, and nutritional deficiencies. The gene's involvement in lipid metabolism suggests that any disruption in its normal function could contribute to the development of pancreatitis, an inflammatory condition of the pancreas. Pancreatitis can cause abdominal pain, nausea, and vomiting, and may lead to more severe complications if not managed properly. Research is ongoing to determine the full extent of PNLIPRP3's clinical implications, as understanding the specific mutations and expression changes that affect its function could provide insights into targeted therapies for these conditions.


## References


[1. (Tripathi2022Quantitative) Priyanka H. Tripathi, Javed Akhtar, Jyoti Arora, Ravindra Kumar Saran, Neetu Mishra, Ravindra Varma Polisetty, Ravi Sirdeshmukh, and Poonam Gautam. Quantitative proteomic analysis of gnrh agonist treated gbm cell line ln229 revealed regulatory proteins inhibiting cancer cell proliferation. BMC Cancer, February 2022. URL: http://dx.doi.org/10.1186/s12885-022-09218-8, doi:10.1186/s12885-022-09218-8. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-022-09218-8)

[2. (Łopucki2018Preliminary) Maciej Łopucki, Jacek Wawrzykowski, Tomasz Gęca, Andrzej Miturski, Monika Franczyk, and Marta Kankofer. Preliminary analysis of the protein profile in saliva during physiological term and preterm delivery. Molecular Medicine Reports, April 2018. URL: http://dx.doi.org/10.3892/mmr.2018.8909, doi:10.3892/mmr.2018.8909. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2018.8909)